On January 13, Harbin Pharmaceutical (Hayao) disclosed its 2024 business plan for health supplement sales during an investor relations event. The company aims to pursue both online and offline expansion while advancing domestic and cross-border operations.
Hayao Health Technology will further strengthen brand awareness, enhance online brand influence, and improve category and product portfolio development. It plans to consolidate its leadership in the liquid nutrition and calcium supplement markets, spearheading category growth. The company will focus on omnichannel e-commerce development, integrating traditional, interest-based, and content-driven e-commerce to drive online sales growth.
GNC China’s operations will continue to be managed by its in-house team, focusing on core distribution channels while expanding its dealer network. Marketing innovation will be driven by GNC’s nine core product lines to further unleash the brand’s potential, securing leadership in niche cross-border segments and enhancing market share and industry position. (Source: Harbin Pharmaceutical)
Sign Up to Receive China Updates Weekly Newsletter for FREE, HERE
Visit HPA-China’s Information Hub, HERE